ProfileGDS4718 / 229132_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 32% 54% 35% 37% 53% 54% 40% 31% 41% 37% 36% 48% 63% 58% 45% 43% 47% 55% 32% 30% 44% 39% 27% 43% 59% 45% 48% 36% 53% 54% 50% 36% 40% 54% 62% 61% 44% 39% 61% 34% 52% 45% 64% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1078342
GSM549102patient 115, normal, homogenized [OPG study]4.6420332
GSM549104patient 119, normal, homogenized [OPG study]5.7383754
GSM549108patient 138, normal, homogenized [OPG study]4.8295535
GSM549119patient 077, normal, homogenized [OPG study]4.8666837
GSM549133patient 032, cancer, homogenized [OPG study]5.6529353
GSM549139patient 042, cancer, homogenized [OPG study]5.7185554
GSM549099patient 107, normal, homogenized [OPG study]4.9927740
GSM549109patient 139, normal, homogenized [OPG study]4.6293331
GSM549110patient 046, normal, homogenized [OPG study]5.0280741
GSM549114patient 063, normal, homogenized [OPG study]4.8196837
GSM549122patient 082, normal, homogenized [OPG study]4.794336
GSM549134patient 033, cancer, homogenized [OPG study]5.3984948
GSM549136patient 036, cancer, homogenized [OPG study]6.3233563
GSM549140patient 044, cancer, homogenized [OPG study]5.9714758
GSM549111patient 047, normal, homogenized [OPG study]5.236645
GSM549113patient 057, normal, homogenized [OPG study]5.0631143
GSM549132patient 031, cancer, homogenized [OPG study]5.3155847
GSM549137patient 038, cancer, homogenized [OPG study]5.7861755
GSM549142patient 047, cancer, homogenized [OPG study]4.7509432
GSM549100patient 110, normal, homogenized [OPG study]4.5730130
GSM549107patient 135, normal, homogenized [OPG study]5.1450144
GSM549115patient 068, normal, homogenized [OPG study]4.9008139
GSM549116patient 072, normal, homogenized [OPG study]4.4213527
GSM549120patient 078, normal, homogenized [OPG study]5.1631343
GSM549131patient 030, cancer, homogenized [OPG study]6.0630559
GSM549118patient 074, normal, homogenized [OPG study]5.2330345
GSM549129patient 027, cancer, homogenized [OPG study]5.4166548
GSM549123patient 088, normal, homogenized [OPG study]4.772736
GSM549124patient 006, cancer, homogenized [OPG study]5.6840953
GSM549126patient 015, cancer, homogenized [OPG study]5.7358454
GSM549128patient 025, cancer, homogenized [OPG study]5.517650
GSM549103patient 117, normal, homogenized [OPG study]4.8804836
GSM549117patient 073, normal, homogenized [OPG study]4.9523740
GSM549138patient 041, cancer, homogenized [OPG study]5.7253854
GSM549141patient 045, cancer, homogenized [OPG study]6.2868662
GSM549130patient 028, cancer, homogenized [OPG study]6.1659561
GSM549101patient 111, normal, homogenized [OPG study]5.2080644
GSM549105patient 128, normal, homogenized [OPG study]4.9590839
GSM549106patient 134, normal, homogenized [OPG study]6.1953561
GSM549112patient 048, normal, homogenized [OPG study]4.7240634
GSM549125patient 011, cancer, homogenized [OPG study]5.6428652
GSM549127patient 024, cancer, homogenized [OPG study]5.2264945
GSM549135patient 035, cancer, homogenized [OPG study]6.4199164